Lv3
368 积分 2020-09-29 加入
Therapeutic potential of interleukin-21 in cancer
20天前
已完结
Advanced cytokine-based immunotherapies: targeted cis-delivery strategies for enhanced anti-tumor efficacy and reduced toxicity
20天前
已完结
Advancements and challenges in immunocytokines: A new arsenal against cancer
20天前
已完结
The present and future of bispecific antibodies for cancer therapy
21天前
已完结
T-cell-engaging bispecific antibodies in cancer
21天前
已完结
The expanding success of T cell-engaging bispecific antibodies
21天前
已完结
Facts and Hopes on Chimeric Cytokine Agents for Cancer Immunotherapy
21天前
已完结
CD28-driven ex vivo generation of stem-like memory CD8+ T cells bypassing CD3/TCR signaling
27天前
已完结
Targeting the stromal-immune barrier: A novel strategy to overcome resistance to CLDN18.2/CD3 bispecific T-cell engager therapy in pancreatic cancer
27天前
已完结
Tumor-targeted IL-10 synergizes with IL-2 to enhance antitumor immunity while minimizing immune-related adverse events
1个月前
已完结
皖公网安备34019202002308
